Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy
review
OA: closed
CC0
⤵ 118 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study compared the long-term effectiveness and safety of dienogest versus a gonadotropin-releasing hormone agonist with add-back hormone therapy for managing endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (93)
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
- Adolescent Endometriosis via openalex
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone via openalex
- All progestins are not created equal via openalex
- Anti-angiogenic treatment strategies for the therapy of endometriosis via openalex
- An update on the pharmacological management of endometriosis via openalex
- A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis via openalex
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex
- Catamenial pneumothorax revisited: Clinical approach and systematic review of the literature via openalex
- Cell growth effects of leuprolide on cultured endometrioma cells. via openalex
- [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis]. via openalex
- Combined Surgical and Hormone Therapy for Endometriosis is the Most Effective Treatment: Prospective, Randomized, Controlled Trial via openalex
- Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive via openalex
- Delayed oral estradiol combined with leuprolide increases endometriosis-related pain. via openalex
- Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. via openalex
- Dienogest via openalex
- Dienogest for the treatment of deep endometriosis: Case report and literature review via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Differential expression of Kisspeptin in patients with and without endometriosis via openalex
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review via openalex
- [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis]. via openalex
- Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis via openalex
- Endometriosis: Diagnosis and Management via openalex
- Endometriosis in an Adolescent Population: The Emory Experience via openalex
- GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down-regulation via openalex
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis via openalex
- Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial via openalex
- Gonadotropin-Releasing Hormone and Its Analogues via openalex
- Gonadotropin-Releasing Hormone and Its Analogues via openalex
- High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners via openalex
- High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners via openalex
- Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Is there a solution for recurrent endometriosis? via openalex
- Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis via openalex
- Low-dose add-back therapy during postoperative GnRH agonist treatment via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Medical Therapy of Endometriosis via openalex
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex
- Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis via openalex
- Ovulation suppression for endometriosis for women with subfertility via openalex
- Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study via openalex
- Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex
- Practice Bulletin No. 114: Management of Endometriosis via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex
- Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
- Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Steroidal ‘Add-Back’ Therapy in Patients Treated with GnRH Agonists via openalex
- The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial via openalex
- The Impact of Excision of Ovarian Endometrioma on Ovarian Reserve: A Systematic Review and Meta-Analysis via openalex
- The use of newer progestins for contraception via openalex
- TNFα-induced IKKβ complex activation influences epithelial, but not stromal cell survival in endometriosis via openalex
- Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy) via openalex
- Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
- W2163315477 via openalex
- W2159369450 via openalex
- W2156535490 via openalex
- W2147342855 via openalex
- W2138336325 via openalex
- W2101417341 via openalex
- W2412679507 via openalex
- W2095424038 via openalex
- W2079421112 via openalex
- W2474876498 via openalex
- W2045458073 via openalex
- W2030585597 via openalex
- W2021687464 via openalex
- W2020712684 via openalex
- W2009719394 via openalex
- W4211081176 via openalex
- W2005761498 via openalex
- W1972978020 via openalex
- W6605167301 via openalex
- W6606179458 via openalex
- W6640084933 via openalex
- W6640900880 via openalex
- W6672127118 via openalex
- W6681100027 via openalex
- W6712393055 via openalex
- W6717470657 via openalex
- W6837363199 via openalex
Cited by (50)
- Pharmacotherapy of Endometriosis: Balancing of Safety, Efficacy, and Adherence to Treatment 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Statins: Is it New Weaponry against Endometriosis? 2025
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- Knowledge, attitudes, and practices of patients with endometriosis regarding endometriosis surgery and postoperative care in Liaoning Province, China: a cross-sectional analysis 2025
- WITHDRAWN: Effects of Deinorgestrel Treatment of Endometriosis on Ovarian Function, Inflammatory Factors, and Pregnancy Rate in Patients 2025
- Identifying key palmitoylation-associated genes in endometriosis through genomic data analysis 2025
- Urogenital endometriosis 2025
- Use of gonadotropic releasing hormone agonists in hyperplastic syndrome in gynecology 2025
- Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review 2025
- Ureteral endometriosis post-hysterectomy for adenomyosis: a case report and literature review 2025
- Additional file 3 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Dienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysis 2024
- A multicentre phase III study comparing efficacy & safety of novel extended-release vs. conventional formulation of Dydrogesterone in Indian patients with endometriosis 2024
- Additional file 3 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Additional file 2 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Additional file 5 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Additional file 1 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Additional file 4 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Additional file 1 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Endometriosis, pregnancy and delivery complications: Evidence from the US nationwide inpatient sample 2005-2018 2024
- Additional file 2 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Comparison of ovarian preservation versus oophorectomy on fertility outcomes in patients with endometriosis post-laparoscopic surgery: A prospective study 2024
- Additional file 4 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- Experimental modeling, prevention, and treatment of endometriosis-associated adhesion formation in NIH/3T3 fibroblast cell line using bovhyaluronidase azoximer (in vitro) 2024
- Additional file 5 of Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery 2024
- A multicentre phase III study comparing efficacy and safety of novel extended-release versus conventional formulation of dydrogesterone in Indian patients with endometriosis 2024
- Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma 2023
- Systematic Review and Meta-analysis on the Effect of Adjuvant Gonadotropin-releasing Hormone Agonist (GnRH-a) on Pregnancy Outcomes in Women with Endometriosis Following Conservative Surgery. 2023
- Abordagens multidisciplinares no manejo da Endometriose: integrando abordagens cirúrgicas e farmacológicas para um tratamento efetivo 2023
- The efficacy of GnRH-a followed by SanJieZhenTong capsules in long-term management of endometriosis: Study protocol for a multicenter, double-blinded, double-dummy randomized clinical trial 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Potential Of Mahkota Dewa Fruit (Phaleria macrocarpa) Flavonoids Extract and Dienogest to Reduce IL-17A Levels in Mice Endometriosis Model 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:37.704673+00:00
License: CC0
· commercial use OK